Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment

Hepatology- United States

doi 10.1002/hep.28916

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

Obesity and Hepatocellular Carcinoma in Patients Receiving Entecavir for Chronic Hepatitis B

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2016English

Low-Level Viremia in Hepatitis B Patients on Antiviral Treatment: Can We Ignore It?

Hepatology
MedicineHepatology
2017English

The HIV Virologic Outcomes of Different Interventions Among Treatment-Experienced Patients With 2 Consecutive Detectable Low-Level Viremia

Journal of the International Association of Physicians in AIDS Care
2011English

Hepatitis B Virus Treatment in Hepatocellular Carcinoma Patients Prolongs Survival and Reduces the Risk of Cancer Recurrence

Clinical and Experimental Hepatology
Hepatology
2018English

Low IgG2 Level and Increased Risk of Infections in Lung Transplant Recipients

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Transient Elastography Is Useful for Evaluating Hepatocellular Carcinoma Development During Entecavir Treatment of Chronic Hepatitis B Virus Infection

Gastroenterology, Hepatology and Endoscopy
2017English

Prognostic Value of Peritumoral Heat-Shock Factor-1 in Patients Receiving Resection of Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2013English

Hepatocellular Carcinoma: Risk Factors, Diagnosis, Staging and Treatment in a Referral Centre

Journal of Cancer Therapy
2013English

TP53 and MDM2 Gene Polymorphisms and Risk of Hepatocellular Carcinoma in Italian Patients

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy